Iqvia Holdings (IQV) | Stock Overview & Key Data
Iqvia Holdings Performance Comparison
Stock Range
Today's Range
Low: $190.08
High: $192.32
on August 15, 2025
52 Week Range
Low: $134.65
High: $252.88
on May 23, 2025
on August 29, 2024
All-Time High: $285.61 on December 27, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$32.5B
EPS
6.90
P/E Ratio (TTM)
27.69
Forward P/E
15.83
P/B Ratio
5.62
PEG Ratio
-1.25
Div. Yield
N/A
ROE
19.79%
Beta
1.300
Debt to Equity
272.12
Financial Highlights
Profitability
Gross Margin
32.94%
Operating Margin
13.39%
Profit Margin
7.88%
Returns and Earnings
Return on Assets (TTM)
5.16%
Return on Equity (TTM)
19.79%
EBITDA
$3.4B
Net Income (TTM)
$1.2B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$89.15
Quarterly Revenue Growth (YoY)
5.30%
Quarterly Earnings Growth (YoY)
-26.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Iqvia Holdings IQV | 32.49B Large-cap | 6.24% | 21.19% | 36.07% | -1.07% | -2.07% | -20.26% | -20.05% | 21.27% |
| Thermo Fisher TMO | 184.66B Large-cap | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% | -19.04% | -16.91% | 14.10% |
| Danaher DHR | 151.04B Large-cap | 5.17% | 9.37% | 10.46% | 3.13% | -8.22% | -21.68% | -18.64% | 14.50% |
| Idexx Laboratories IDXX | 52.07B Large-cap | -1.10% | 23.58% | 27.12% | 44.93% | 59.19% | 32.21% | 74.14% | 69.73% |
| Agilent Technologies A | 33.86B Large-cap | 4.00% | 5.54% | 6.05% | -11.83% | -10.66% | -14.88% | -13.38% | 21.26% |
| Mettler-Toledo MTD | 27.03B Large-cap | 4.49% | 12.30% | 14.78% | 3.08% | 7.50% | -7.42% | -1.61% | 36.70% |
Ownership & Short Interest
Insider Ownership
1.05%
Institutional Ownership
102.10%
Shares Short
7M
Short Ratio
2.96
Short % of Shares Outstanding
4.66%
Average 10-Day Volume
1M
Average 90-Day Volume
2M
Iqvia Holdings Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Iqvia Holdings would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IQV's 52-week high and low?
- In the last 52 weeks, Iqvia Holdings reached a high of $252.88 (on August 29, 2024) and a low of $134.65 (on May 23, 2025).
- What is the market cap and P/E ratio for IQV?
- Curious about Iqvia Holdings's size and valuation? Its market capitalization stands at 32.49B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.69, and the forward P/E (looking ahead) is 15.83.
- Does IQV pay dividends? If so, what's the yield?
- As for dividends, Iqvia Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Iqvia Holdings's main competitors or similar companies to consider before investing?
When looking at Iqvia Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.66B Healthcare Diagnostics & Research -19.04% -16.91% Danaher
DHR151.04B Healthcare Diagnostics & Research -21.68% -18.64% Idexx Laboratories
IDXX52.07B Healthcare Diagnostics & Research 32.21% 74.14% Agilent Technologies
A33.86B Healthcare Diagnostics & Research -14.88% -13.38% Mettler-Toledo
MTD27.03B Healthcare Diagnostics & Research -7.42% -1.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Iqvia Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Iqvia Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.79%, the Debt to Equity ratio from the most recent quarter is 272.12, and its Gross Profit Margin stands at 32.94%.
- What is the recent revenue and earnings growth for IQV?
- Looking at Iqvia Holdings's growth, its revenue over the trailing twelve months (TTM) was $16B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.30%, and quarterly earnings saw a YoY growth of -26.70%.
- How much of IQV stock is held by insiders and institutions?
- Wondering who owns Iqvia Holdings stock? Company insiders (like executives and directors) hold about 1.05% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 102.10%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.